ESSA Pharma to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

ESSA Pharma (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate cancer, announced it will present at the Jefferies Global Healthcare Conference on June 6, 2024, at 12:30 p.m. ET in New York.

Company executives David R. Parkinson (President & CEO) and David S. Wood (CFO) will host and participate in one-on-one meetings.

The event will be webcast live and available on the ESSA website for 90 days.

Positive

• Participation in a high-profile conference can enhance investor interest.
• Opportunity for live engagement with investors and stakeholders via webcast.
• Archived webcast availability extends the reach and impact of the presentation.

Negative

• No new financial or clinical data disclosed in the announcement.
• Potential investor expectations may not be met without substantive news.
• Costs associated with conference participation may impact financials.

SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, May 30, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York.

David. R. Parkinson, President, and Chief Executive Officer and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com, and follow us on Twitter and LinkedIn.

Contacts

ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
pvirsik@essapharma.com 

Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-the-jefferies-global-healthcare-conference-302158625.html

SOURCE ESSA Pharma Inc

FAQ

When will ESSA Pharma present at the Jefferies Global Healthcare Conference?

ESSA Pharma will present on June 6, 2024, at 12:30 p.m. ET.

What is the stock symbol for ESSA Pharma?

ESSA Pharma is listed under the stock symbol EPIX on NASDAQ.

Who will represent ESSA Pharma at the Jefferies Global Healthcare Conference?

David R. Parkinson, President & CEO, and David S. Wood, CFO, will represent ESSA Pharma.

How can I watch the ESSA Pharma presentation at the Jefferies Global Healthcare Conference?

The presentation will be webcast live on the ESSA website and archived for 90 days.